STUDY OF THE EFFECTIVENESS AND SAFETY OF CABOZANTINIB TREATMENT IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC) UNDER A SPANISH MANAGED ACCESS PROGRAM AND REAL-WORLD PRACTICE.

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)

Gately L; (...); Balana C

Correction. 10.1007/s11060-024-04581-x. 2024

• 
• 
• 1

  

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Gately, L.; (...); Balana, C.

Article. 10.1007/s11060-023-04513-1. 2023

• 
• 2

  

A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA

Gately, Lucy; (...); Balana, Carmen

Meeting Abstract. 2023

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond six cycles in patients with glioblastoma (GEINO 14-01).

Balana C; (...); Carrato C

Article. 10.1093/neuonc/noaa107. 2020

• 
• 
• 87

  

Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.

Battisti NML; (...); Wildiers H

Review. 10.1016/j.jgo.2020.07.008. 2020

• 
• 
• 70

  

Addressing the challenges of cancer care in older adults: The unique benefits of oncogeriatric evaluation and management.

Martinez-Peromingo, Javier; (...); Girones, Regina

Letter. 10.1016/j.regg.2023.03.002. 2023

• 
• 3

  

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Garrido Siles, Marga; (...); Angel Climent, Miguel

Review. 10.3390/cancers14163968. 2022

• 
• 
• 2

  

Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial.

Garcia-Del-Muro, Xavier; (...); Alemany, Ramon

Article. 10.1158/1078-0432.CCR-24-2636. 2025

Consensus on strategies in the management of opioid-induced constipation in cancer patients

Sarrio, RG; (...); Sales, JP

Meeting Abstract. 2019

Correction: Update on the management of elderly patients with colorectal cancer.

Soler-González G; (...); Gironés-Sarrió R

Correction. 10.1007/s12094-023-03351-x. 2024

COVID-19 and hospitalised cancer patients: Now it's time for patients to talk

Arrue, BD; (...); Sarrio, RG

Meeting Abstract. 10.1016/j.annonc.2020.08.2061. 2020

Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

Sarrio, RG; (...); Porta-Sales, J

Article. 10.1186/s12904-020-00693-z. 2021

• 
• 
• 17

  

Development and validation of an early death risk score for older patients treated with chemotherapy for cancer.

Batlle, JF; (...); Molina-Garrido, MJ

Meeting Abstract. 2020

Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer

Feliu, J; (...); Molina-Garrido, MJ

Article. 10.3390/jcm10081615. 2021

• 
• 
• 12

  

Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis.

Angeles Vaz, Maria; (...); De Las Penas Bataller, Ramon

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14046. 2021

Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma

Villar, MV; (...); Santos, JD

Meeting Abstract. 10.1016/j.annonc.2021.08.008. 2021

Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.

Nadal E; (...); Gironés R

Article. 10.1007/s12094-023-03286-3. 2023

• 
• 
• 2

  

Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer.

Torregrosa-Maicas MD; (...); Gironés-Sarrió R

Article. 10.1007/s12094-021-02766-8. 2022

• 
• 
• 12

  

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Gately L; (...); Balana C

Article. 10.1007/s11060-024-04668-5. 2024

• 
• 1

  

Final database lock results of the phase 2 cohort of lenvatinib plus pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma

Lee, Chung-Han; (...); Motzer, Robert J.

Meeting Abstract. 2023

Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

Vaz, M. A.; (...); Girones, R.

Meeting Abstract. 10.1016/j.annonc.2023.09.1695. 2023

• 
• 1

  

Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: a multicenter prospective study.

Rondan, Maria Arnal; (...); Sarrio, Regina Girones

Article. 10.1007/s12094-024-03657-4. 2024

Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.

Vaz Salgado, Maria Angeles; (...); De Las Penas Bataller, Ramon

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14047. 2021

Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives.

Mizutani, Tomonori; (...); Kanesvaran, Ravindran

Article. 10.1016/j.jgo.2024.101709. 2024

• 
• 
• 1

  

Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Lee, Chung-Han; (...); Motzer, Robert J

Letter. 10.1016/j.eururo.2024.05.003. 2024

• 4

  

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

Lee, CH; (...); Motzer, JR

Article. 10.1016/S1470-2045(21)00241-2. 2021

• 
• 
• 145

  

P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY

Mazariegos, M.; (...); Pineda, E.

Meeting Abstract. 10.1093/neuonc/noae144.446. 2024

Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.

Aparicio, J.; (...); Germa, J. R.

Article. 10.1007/s12094-020-02393-9. 2021

• 
• 7

  

Phase II trial evaluating olaparib maintenance in patients with metastatic castration resistant prostate cancer (mCRPC) after docetaxel treatment, reaching partial or stable response: SOGUG-IMANOL study.

Juan Fita, Maria Jose; (...); Heras, Lucia

Meeting Abstract. 2023

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.

Juan Fita, Maria Jose; (...); Angel Climent, Miguel

Article. 10.3390/cancers15215223. 2023

• 
• 
• 1

  

Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.

Garcia del Muro, Xavier; (...); Vigues, Francesc

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.4505. 2021

• 33

  

Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy as bladder-sparing therapy in patients with localized muscle invasive bladder cancer: A SOGUG study.

Cuellar, M. Andres; (...); Garcia del Muro, Xavier

Meeting Abstract. 2020

Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell renal cell carcinoma (mccRCC).

Lee, CH; (...); Motzer, RJ

Meeting Abstract. 2020

Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for progressive disease after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell (mcc) renal cell carcinoma (RCC): Results by independent imaging review and subgroup analyses

Lee, CH; (...); Motzer, RJ

Meeting Abstract. 10.1016/j.annonc.2020.08.782. 2020

• 
• 5

  

Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients

Duran, MAC; (...); Nunez, NF

Meeting Abstract. 10.1016/j.annonc.2020.08.2074. 2020

• 
• 1

  

Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.

Girones, Regina, Arnal, Maria, Forcano, Silvia

Meeting Abstract. 2023

Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)

Redondo, Andres; (...); Gonzalez-Martin, Antonio

Article. 10.31083/j.ejgo4206163. 2021

• 
• 
• 1

  

Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

Vaz, Maria Angeles; (...); Martinez-Garcia, Maria

Meeting Abstract. 2022

SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).

Martínez-García M; (...); Manuel Sepúlveda-Sánchez J

Article. 10.1007/s12094-022-02803-0. 2022

• 
• 
• 4

  

SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).

Segura, Pedro Perez; (...); Losada, Estela Pineda

Article. 10.1007/s12094-023-03245-y. 2023

• 
• 
• 15

  

SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer.

Russo, Chiara; (...); Battisti NML

Article. 10.1016/j.jgo.2023.101564. 2023

• 
• 
• 1

  

SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain.

Juan Fita, Maria Jose; (...); Molina Diaz, Aurea

Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.e1656. 2024

State of the scientific evidence and recommendations for the management of older patients with gastric cancer.

Paredero-Perez, Irene; (...); Girones-Sarrio, Regina

Article. 10.1016/j.jgo.2023.101657. 2023

• 
• 
• 2

  

Strategies to enhance management of HER2-positive breast cancer in the elderly: an expert consensus perspective.

Del Barco, Sonia; (...); Servitja, Sonia

Article. 10.1007/s12094-024-03838-1. 2025

Survival, quality of life (QoL) and geriatric outcomes of elderly patients (pt) with advanced non-small cell lung cancer (NSCLC), treated with pembrolizumab (P) in the first-line setting

Blanco, R; (...); Vidal, OJJ

Meeting Abstract. 10.1016/j.annonc.2020.08.1631. 2020

• 
• 3

  

The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer.

Mislang AR; (...); Battisti NML

Letter. 10.1016/j.jgo.2021.03.003. 2021

• 
• 
• 12

  

Undertreatment and overtreatment in older patients treated with chemotherapy.

Feliu J; (...); Molina-Garrido MJ

Article. 10.1016/j.jgo.2020.10.010. 2020

• 
• 20

  

Update on the management of elderly patients with colorectal cancer.

Soler-Gonzalez, Gemma; (...); Girones-Sarrio, Regina

Article. 10.1007/s12094-023-03243-0. 2023

• 
• 
• 7

  

Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.

Guillot Morales M; (...); Gironés Sarrió R

Article. 10.1007/s12094-024-03386-8. 2024

• 
• 
• 1

  

Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer.

Soto-Perez-de-Celis, Enrique; (...); Battisti, Nicolo Matteo Luca

Article. 10.1016/j.jgo.2022.07.005. 2022

• 
• 
• 2